EUVIMEDEUVIMED entdecken
Crossref

Evolving Strategies in Lymphedema Surgery

Hyung Hwa Jeong

Clinical Lymphology and Lymphedema · 2026-05 · 11 (1) · 38-40

DOI: 10.67326/cll.2026.11.1.38 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphology and Lymphedema, online erschienen am 22.05.2026. Verfasst von Hyung Hwa Jeong.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The surgical management of lymphedema has evolved substantially, shifting from ablative approaches toward physiologic reconstruction aimed at restoring lymphatic drainage. Ablative procedures, including suction-assisted liposuction and excisional techniques, continue to play a meaningful role in symptom control and may be combined synergistically with physiologic surgery. Physiologic procedures — principally lymphaticovenular anastomosis (LVA) — are most effective in early-stage disease, where residual lymphatic function remains intact. Emerging adjunctive therapies, including nanofibrillar collagen scaffolds aim to promote lymphangiogenesis and extend the reach of physiologic reconstruction. A comprehensive, stage-specific treatment algorithm integrating these modalities represents the foremost goal in advancing lymphatic surgery.

Zitieren

APA

Jeong, H. H. (2026). Evolving Strategies in Lymphedema Surgery. Clinical Lymphology and Lymphedema, 11(1), 38-40. https://doi.org/10.67326/cll.2026.11.1.38

Vancouver

Jeong HH. Evolving Strategies in Lymphedema Surgery. Clinical Lymphology and Lymphedema. 2026;11(1):38-40. doi:10.67326/cll.2026.11.1.38

BibTeX
@article{Jeong2026,
  author = {Jeong, Hyung Hwa},
  title = {Evolving Strategies in Lymphedema Surgery},
  journal = {Clinical Lymphology and Lymphedema},
  year = {2026},
  volume = {11},
  number = {1},
  pages = {38--40},
  doi = {10.67326/cll.2026.11.1.38}
}
Kostenlos starten →